DoW Arthritis Clinical Research Award
Defense Health Agency Contracting Activity - DHACA
Free. Verify your email, then we send one reminder only.
- Posted
- May 1, 2026
- Amount
- Program total $7.2M
- Closes
- Oct 22, 2026 (in 38 days)
Similar opportunities open now
- DoW Arthritis Translational Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 38 days
- DoW Orthopaedic, Clinical Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 65 days
- DoW Orthopaedic, Applied Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 65 days
- DoW Autism Clinical Trial AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 38 days
- DoW Peer Reviewed Medical, Clinical Trial AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 8 days
Classification and identifiers
- Solicitation number
- HT942526ATRPCRA
- Assistance listing (CFDA)
- 12.420
Amount
Program total $7.2M
Who can apply
About this opportunity
Summary: The fiscal year 2026 (FY26) Arthritis Research Program (ATRP) Clinical Research Award (CRA) supports clinical research that evaluates disease-specific factors and interventions. Research is intended to generate clinically useful evidence with potential to optimize patient outcomes and inform clinical care or policy. Research addressing any and all types of arthritis is encouraged. Applications must address one of two FY26 ATRP CRA Focus Areas: Prevention and Early Diagnosis, or Treatment and Mitigation of Disease Progression/Burden. Distinctive Features: The FY26 ATRP CRA offers funding for two research levels. It is the responsibility of the applicant to select the level that aligns with the scope of the proposed research. • Research Level 1: Applications proposing clinical resea...